⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 4, 2024

Supplementary Fiugre S4 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy

Elisabeth I. Heath Gregory Dyson Jennifer R. Ribeiro Joanne Xiu Kelsey Poorman Hirva Mamdani Mohammed Najeeb Al Hallak Anthony F. Shields Jailan A. Elayoubi Ira Winer Frank C. Cackowski Gary A. Puckrein Gilberto Lopes Nathaniel Jones Ralph J. Hauke Samuel A. Kareff Milan Radovich George W. Sledge David Spetzler Gregory A. Vidal John L. Marshall

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Overall survival by RUCA code and poverty

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Heath et al. (2024) studied this question.

synapsesocial.com/papers/68e55da7e2b3180350efac01 https://doi.org/10.1158/2767-9764.27169565

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S3 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy2024
2Supplementary Figure S7 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy2024
3Supplementary Figure S2 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy2024
4Supplementary Figure S5 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy2024
5Supplementary Figure S8 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy2024

Supplementary Figure S6 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy2024
Supplementary Figure S1 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy2024
Figure 4 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy2024